| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/09/2012 | US20120035268 Sphingo-guanidines and their use as inhibitors of sphingosine kinase |
| 02/09/2012 | US20120035266 Bis(thio-hydrazide amide) salts for treatment of cancers |
| 02/09/2012 | US20120035257 Histone Deacetylase Inhibitors |
| 02/09/2012 | US20120035255 Derivative of [(3-hydroxy-4 pyron-2-yl)-methyl]-amine and use thereof as anti-neoplastic drugs |
| 02/09/2012 | US20120035253 Crystalline forms of genistein |
| 02/09/2012 | US20120035251 Thiophene inhibitors of ikk-b serine-threonine protein kinase |
| 02/09/2012 | US20120035244 Parp1 targeted therapy |
| 02/09/2012 | US20120035238 Compounds and methods for treating cancer and viral infections |
| 02/09/2012 | US20120035231 Specific diarylhydantoin and diarylthiohydantoin compounds |
| 02/09/2012 | US20120035227 Deuterium-enriched ixabepilone |
| 02/09/2012 | US20120035217 Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors |
| 02/09/2012 | US20120035212 (L)-Malate salt of N-(4-phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide |
| 02/09/2012 | US20120035209 Hydroxy Substituted 1H-Imidazopyridines and Methods |
| 02/09/2012 | US20120035208 Pyrazolopyridine pi3k inhibitor compounds and methods of use |
| 02/09/2012 | US20120035206 Preparation and application of novel antibacterial and anticancer compounds and their derivatives |
| 02/09/2012 | US20120035205 Treatment for basal cell carcinoma |
| 02/09/2012 | US20120035200 Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering |
| 02/09/2012 | US20120035192 Selective antagonists of a2a adenosine receptors |
| 02/09/2012 | US20120035191 Deuterium-enriched pyrimidine compounds and derivatives |
| 02/09/2012 | US20120035187 Anti-neurodegenerative disease agent |
| 02/09/2012 | US20120035184 Methods for inducing tumor regression, inhibiting tumor growth, and inducing apoptosis in breast tumors with geranylgeranyltransferase i inhibitors |
| 02/09/2012 | US20120035183 Cancer Treatment Method |
| 02/09/2012 | US20120035180 Pharmaceutical composition for treating cancer comprising chlorin e6-folic acid conjugate compound and chitosan |
| 02/09/2012 | US20120035179 Modulators of atp-binding cassette transporters |
| 02/09/2012 | US20120035176 Analogs of 3-o-acetyl-11-keto-beta-boswellic acid |
| 02/09/2012 | US20120035175 Novel salts as Anti-Inflammatory, Immunomodulatory and Anti-Proliferatory Agents |
| 02/09/2012 | US20120035174 Salts of N-[6-cis-2,6-Dimethylmorpholin-4-yl)pyridine-3-yl]-2-methyl-4'-(trifluoromethoxy)[1,1'-biphenyl]-3-carboxamide |
| 02/09/2012 | US20120035171 Bicyclic heterocyclyl derivatives as fgfr kinase inhibitors for therapeutic use |
| 02/09/2012 | US20120035164 Chemical compounds |
| 02/09/2012 | US20120035153 Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors |
| 02/09/2012 | US20120035152 Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors |
| 02/09/2012 | US20120035151 Substituted dihydropyrazolones and their use |
| 02/09/2012 | US20120035150 Mif inhibitors and their uses |
| 02/09/2012 | US20120035145 Methods of treating multiple myeloma using melphalan, prednisone and lenalidomide |
| 02/09/2012 | US20120035140 Carbamoylphosphonates as inhibitors and uses thereof |
| 02/09/2012 | US20120035137 Use of inositol-tripyrophosphate in treating tumors and diseases |
| 02/09/2012 | US20120035134 Chemical compounds |
| 02/09/2012 | US20120035133 Lyophilization Cakes of Proteasome Inhibitors |
| 02/09/2012 | US20120035127 Process for the production of a composition, the composition and the use thereof as food additive |
| 02/09/2012 | US20120035126 Compounds For Reducing Drug Resistance And Uses Thereof |
| 02/09/2012 | US20120035120 Glycolipids as treatment for disease |
| 02/09/2012 | US20120035115 Chemical modifications of monomers and oligonucleotides with cycloaddition |
| 02/09/2012 | US20120035114 Inhibitors of stat3 and uses thereof |
| 02/09/2012 | US20120034651 Akt activity specifically inhibiting polypeptide |
| 02/09/2012 | US20120034609 Gene detection assay for improving the likelihood of an effective response to an egfr antagonist cancer therapy |
| 02/09/2012 | US20120034318 Diagnostic method using palb2 |
| 02/09/2012 | US20120034317 Prediction of Response to Platinum-Based Therapy |
| 02/09/2012 | US20120034316 Pharmaceutical compositions for dehydrating, atrophying and eliminating pathological tissues |
| 02/09/2012 | US20120034310 Nutraceutical for the prevention and treatment of cancers and diseases affecting the liver |
| 02/09/2012 | US20120034271 Injectable in-situ crosslinked hydrogel and methods of making and using thereof |
| 02/09/2012 | US20120034270 S1P Receptors Modulators |
| 02/09/2012 | US20120034269 Analogs of alpha galactosylceramide and uses thereof |
| 02/09/2012 | US20120034268 Bacterial ghosts for mediating innate immunity |
| 02/09/2012 | US20120034251 Pharmaceutical composition for treating or preventing cancer by inducing dendritic cell-like differentiation from monocytes to improve anticancer immune activity |
| 02/09/2012 | US20120034249 Methods for Treating Progressive Multifocal Leukoencephalopathy (PML) |
| 02/09/2012 | US20120034247 Monomethylvaline compounds capable of conjugation to ligands |
| 02/09/2012 | US20120034246 Monomethylvaline compounds capable of conjugation to ligands |
| 02/09/2012 | US20120034245 Single-chain multivalent binding proteins with effector function |
| 02/09/2012 | US20120034244 Methods of treating secondary bone tumors with antibodies against pdgfr alpha |
| 02/09/2012 | US20120034242 Cytokine-expressing cellular vaccine combinations |
| 02/09/2012 | US20120034237 Antibodies directed to angiopoietin-1 and angiopoietin-2 and uses thereof |
| 02/09/2012 | US20120034236 Co-targeting of aurora a kinase and lim kinase 1 for cancer therapy |
| 02/09/2012 | US20120034235 Marker for Liver-Cancer Diagnosis and Recurrence and Survival Prediction, a Kit Comprising the Same, and Prognosis Prediction in Liver-Cancer Patients Using the Marker |
| 02/09/2012 | US20120034232 Tlr3 binding agents |
| 02/09/2012 | US20120034229 Monoclonal antibodies directed against lg4-5 domain of alpha3 chain of human laminin-5 |
| 02/09/2012 | US20120034228 CROSS-SPECIES-SPECIFIC PSCAxCD3, CD19xCD3, C-METxCD3, ENDOSIALINxCD3, EPCAMxCD3, IGF-1RxCD3 OR FAPALPHAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY |
| 02/09/2012 | US20120034227 Monoclonal antibody therapy for pancreas cancer |
| 02/09/2012 | US20120034222 Nitric Oxide Generating Medical Devices |
| 02/09/2012 | US20120034221 T-Cell Receptor Antibodies And Methods of Use Thereof |
| 02/09/2012 | US20120034220 Mucin Fusion Polypeptide Vaccines, Compositions And Methods Of Use Thereof |
| 02/09/2012 | US20120034219 Uses of il-23 agonists and antagonists; related reagents |
| 02/09/2012 | US20120034218 RBM3 in Colorectal Cancer Prognostics |
| 02/09/2012 | US20120034217 Anti-neoplastic compositions comprising extracts of black cohosh |
| 02/09/2012 | US20120034216 Spiroketals |
| 02/09/2012 | US20120034215 Anti-mst1r antibodies and uses thereof |
| 02/09/2012 | US20120034214 Methods and kits for determining the prognosis of pulmonary sarcoidosis |
| 02/09/2012 | US20120034213 TREATMENT WITH ANTI-ErbB2 ANTIBODIES |
| 02/09/2012 | US20120034212 Human Anti-IL-6 Antibodies With Extended In Vivo Half-Life And Their Use In Treatment Of Oncology, Autoimmune Diseases And Inflammatory Diseases |
| 02/09/2012 | US20120034211 EGFR antibodies comprising modular recognition domains |
| 02/09/2012 | US20120034210 Compositions for potentiating apoposis signals in tumour cells |
| 02/09/2012 | US20120034208 Treating Breast Cancer with Anti-IL-19 Antibody |
| 02/09/2012 | US20120034207 Production of her receptor antibodies in plant |
| 02/09/2012 | US20120034206 Breast cancer eradication program |
| 02/09/2012 | US20120034201 Composition for regulating lipid metabolism |
| 02/09/2012 | US20120034193 Treatment of neurotrophic factor mediated disorders |
| 02/09/2012 | US20120034186 Indoline scaffold shp-2 inhibitors and method of treating cancer |
| 02/09/2012 | US20120034185 Anti-cd20 antibodies and fusion proteins therof and methods of use |
| 02/09/2012 | US20120034169 Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications |
| 02/09/2012 | US20120034168 Isolated Monoclonal Antibody or Fragment Thereof Binding Prostate Specific Membrane Antigen, Conjugates and Uses Thereof |
| 02/09/2012 | US20120034167 Tyrosine kinase receptor tyro3 as a therapeutic target in the treatment of cancer |
| 02/09/2012 | US20120034164 Truncated car peptides and methods and compositions using truncated car peptides |
| 02/09/2012 | US20120034160 Dual variable domain immunoglobulins and uses thereof |
| 02/09/2012 | US20120034159 Antibodies that bind both bcma and taci |
| 02/09/2012 | CA2817925A1 Compositions and methods for detecting, diagnosing, and treating cancer |
| 02/09/2012 | CA2807498A1 2-substituted-8-alkyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidine-6-carbonitriles and uses thereof |
| 02/09/2012 | CA2807274A1 Interior functionalized hyperbranched dendron-conjugated nanoparticles and uses thereof |
| 02/09/2012 | CA2807263A1 Novel artemisinin-like derivatives with cytotoxic and anti-angiogenic properties |
| 02/09/2012 | CA2807230A1 Compounds and compositions for mitigating tissue damage and lethality |
| 02/09/2012 | CA2807149A1 Novel treatment of prostate carcinoma |
| 02/09/2012 | CA2807141A1 Compositions and methods for inducing immune tolerance |